More on VRDN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.9 Score)

Upcoming Events

- Earnings (11/16/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Viridian Therapeutics (NQ:VRDN)
Delayed: 23.03 -0.13 (0.56%)
Prev. Close $23.16  
Open$23.02 
52 Wk High$ 
52 Wk Low$ 
Day High$23.34 
Day Low$22.89 
P/E N/A  
EPS$ 
Volume998,384 

Friends, Peers and Foes (?): ARWR, XENE, AMLX, ANAB, DRUG (more...)

Aug 20, 2026 08:05 PM Form 4 Viridian Therapeutics, For: Aug 19 Filed by: Tousignant Jennifer
Aug 20, 2026 04:15 PM Form SCHEDULE 13G Viridian Therapeutics, Filed by: Point72 Asset Management, L.P.
Aug 19, 2026 02:31 PM Form 144 Viridian Therapeutics, Filed by: Tousignant Jennifer
Aug 18, 2026 05:34 PM Form 4 Viridian Therapeutics, For: Aug 14 Filed by: Tripuraneni Radhika
Aug 14, 2026 04:32 PM Form SCHEDULE 13G/A Viridian Therapeutics, Filed by: Paradigm Biocapital Advisors LP
Aug 14, 2026 12:18 PM Form SCHEDULE 13G/A Viridian Therapeutics, Filed by: Kynam Capital Management, LP
Aug 14, 2026 10:40 AM Form SCHEDULE 13G Viridian Therapeutics, Filed by: PRICE T ROWE ASSOCIATES INC /MD/
Aug 14, 2026 08:33 AM Form SCHEDULE 13G/A Viridian Therapeutics, Filed by: Deep Track Capital, LP
Aug 7, 2026 11:13 AM Form SCHEDULE 13G Viridian Therapeutics, Filed by: STATE STREET CORP
Aug 6, 2026 03:02 PM Viridian Reports Continuation of Massive Sulphides at Kraken Main; First Assays Pending
View All Articles

Entities mentioned with VRDN

View All Entities